52010PC0397

Togra le haghaidh RIALACHÁIN Ó PHARLAIMINT NA hEORPA AGUS ÓN gCOMHAIRLE lena ndéantar foráil chun déileáil ar bhonn saor ó dhleacht le comhábhair shonraithe ghníomhacha chógaisíochta ar a bhfuil "ainm neamhdhílseánaigh idirnáisiúnta (ANI)" ón Eagraíocht Dhomhanda Sláinte agus le táirgí sonraithe a úsáidtear chun cógais chríochnaithe a mhonarú agus lena leasaítear Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87 /* COM /2010/0397 final COD 2010/0214 */


[pic] | AN COIMISIÚN EORPACH |

An Bhruiséil 27.7.2010

COIM(2010)397 leagan deireanach

2010/0214 (COD)

Togra le haghaidh

RIALACHÁIN Ó PHARLAIMINT NA hEORPA AGUS ÓN gCOMHAIRLE

lena ndéantar foráil chun déileáil ar bhonn saor ó dhleacht le comhábhair shonraithe ghníomhacha chógaisíochta ar a bhfuil "ainm neamhdhílseánaigh idirnáisiúnta (ANI)" ón Eagraíocht Dhomhanda Sláinte agus le táirgí sonraithe a úsáidtear chun cógais chríochnaithe a mhonarú agus lena leasaítear Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87

MEABHRÁN MÍNIÚCHÁIN

Is é atá sa Taifead ar an bPlé faoi Thrádáil i dTáirgí Cógaisíochta socrú idir na tíortha is mó a tháirgeann cógais chun na dualgais a cheanglaíonn an Eagraíocht Dhomhanda Trádála (EDT) orthu maidir le dleachtanna a laghdú go náid, agus é sin a dhéanamh ar bhonn an Náisiúin Bharrfhabhair (MFN), ar dleachtanna iad ar tháirgí cógaisíochta áirithe, lena n-áirítear comhábhair ghníomhacha agus táirgí idirmheánacha. Is iad na Páirtithe sa Chomhaontú sin an AE, Stáit Aontaithe Mheiriceá, an tSeapáin, Ceanada, an Eilvéis, an Iorua agus Macao (an tSín).

I dtosach, chuimsigh an socrú níos mó ná sé mhíle táirge. Ós rud é, áfach, go bhfuil táirgí nua cógaisaíochta á bhforbairt an t-am ar fad, déantar foráil sa socrú d'athbhreithnithe tráthrialta. D'aontaigh na Páirtithe "go mbuailfeadh siad le chéile faoi choimirce Chomhairle um Thrádáil Earraí an EDT, ar a laghad uair gach trí bliana, chun athbhreithniú a dhéanamh ar chuimsiú na dtáirgí d'fhonn táirgí breise cógaisíochta a chur san áireamh, trí chomhthoil, do scrios na taraife." Rinneadh athbhreithniú ar an gcuimsiú den chéad uair i 1995-1996 agus, dá thoradh sin, rinneadh an cinneadh déileáil le 465 táirge breise ar bhonn saor ó dhleacht. Mar thoradh ar an dara hathbhreithniú i 1998 (arna chur chun feidhme i mí Iúil 1999) déileáladh le 639 táirge breise ar bhonn saor ó dhleacht. Mar thoradh ar an tríú hathbhreithniú in 2006 cuireadh 1290 táirgí leis an méid sin.

Leis an togra seo, iarrtar ar an gComhairle agus ar an bParlaimint cead a thabhairt 718 táirge cógaisíochta agus ceimiceach a chur leis an liosta atá ann cheana ar a bhfuil 8619 táirge, a bhfuil ceangal ann déileáil leo ar bhonn saor ó dhleacht, nuair a allmhairítear san AE iad.

In 2009, cuireadh tús leis an gceathrú hathbhreithniú ar na táirgí atá cuimsithe sa Taifead, i gcomhréir le hAirteagal 3 den Taifead, Airteagal lena gcuirtear de cheangal ar Rannpháirtithe athbhreithniú a dhéanamh, ar a laghad uair gach trí bliana, ar chuimsiú na dtáirgí d'fhonn táirgí breise cógaisaíochta a chur san áireamh do scrios na taraife. Ghlac an AE páirt sa phlé teicniúil sin. Le linn an phlé sin, tháinig Rannpháirtithe ar an gconclúid, maidir le ANInna breise agus le táirgí idirmheánacha cógaisíochta a úsáidtear chun cógais chríochnaithe a tháirgeadh agus a mhonarú, gur cheart déileáil leo ar bhonn saor ó dhleacht agus maidir le liosta na réimíreanna agus na n-iarmhíreanna sonraithe le haghaidh salann, eistear nó hiodráití d'ANInna, gur cheart cur leis, sa chaoi sin ag cur 718 substaint nua le liosta na dtáirgí ar féidir déileáil leo ar bhonn saor ó dhleacht.

Chuathas i gcomhairle leis na Ballstáit le linn an phlé theicniúil.

Iarrtar ar an gComhairle agus ar an bParlaimint an togra a ghabhann leis seo a ghlacadh, is é sin an togra le haghaidh Rialacháin ó Pharlaimint na hEorpa agus ón gComhairle lena leasaítear Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87 maidir le síneadh ar dhéileáil leis na táirgí cógaisíochta agus ceimiceacha thuasluaite ar bhonn saor ó dhleacht san Aontas Eorpach.

2010/0214 (COD)

Togra le haghaidh

RIALACHÁIN Ó PHARLAIMINT NA hEORPA AGUS ÓN gCOMHAIRLE

lena ndéantar foráil chun déileáil ar bhonn saor ó dhleacht le comhábhair shonraithe ghníomhacha chógaisíochta ar a bhfuil "ainm neamhdhílseánaigh idirnáisiúnta (ANI)" ón Eagraíocht Dhomhanda Sláinte, agus le táirgí sonraithe a úsáidtear chun cógais chríochnaithe a mhonarú agus lena leasaítear Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87

TÁ PARLAIMINT NA HEORPA AGUS COMHAIRLE AN AONTAIS EORPAIGH,

Ag féachaint don Chonradh ar Fheidhmiú an Aontais Eorpaigh, agus go háirithe Airteagal 207 de,

Ag féachaint don togra ón gCoimisiún Eorpach,

Tar éis dóibh an dréachtghníomh reachtach a chur chuig na Parlaimintí náisiúnta,

Ag gníomhú dóibh i gcomhréir leis an ngnáthnós imeachta reachtach,

De bharr an méid seo a leanas:

(1) Le linn na caibidlíochta a bhain le Babhta Uragua, d'aontaigh an Comhphobal agus roinnt tíortha gur cheart déileáil ar bhonn saor ó dhleacht le táirgí cógaisíochta a thagann faoi Chaibidil 30 den Chóras Comhchuibhithe (CC) agus faoi cheannteidil CC 2936, 2937, 2939 agus 2941, mar aon le comhábhair shonraithe ghníomhacha chógaisíochta ar a bhfuil "ainm neamhdhílseánaigh idirnáisiúnta (ANI)" ón Eagraíocht Dhomhanda Sláinte (EDT), le salainn shonraithe, eistir shonraithe nó hiodráití sonraithe na nANInna sin, agus le táirgí sonraithe idirmheánacha cógaisíochta a úsáidtear chun cógais chríochnaithe a tháirgeadh agus a mhonarú.

(2) Ionchorpraíodh torthaí an phlé sin, mar a leagadh amach iad i dtaifead an phlé, i sceidil taraifí na rannpháirtithe a cuireadh i gceangal le Prótacal Marrakech a ghabhann leis an gComhaontú Ginearálta um Tharaifí agus Trádáil 1994.

(3) D'aontaigh na Páirtithe go mbuailfeadh ionadaithe chomhaltaí an EDT le chéile faoi choimirce Chomhairle um Thrádáil Earraí an EDT, ar a laghad uair gach trí bliana, chun cuimsiú na dtáirgí a athbhreithniú d'fhonn táirgí breise cógaisíochta a chur san áireamh, trí chomhthoil, do scrios na taraife. Is páirtithe iad comhaltaí an EDT i dtaifead an phlé.

(4) Mar thoradh ar thrí athbhreithniú atáthar tar éis a dhéanamh, déileáiltear ar bhonn saor ó dhleacht le líon áirithe ANInna breise agus le líon áirithe táirgí idirmheánacha cógaisíochta a úsáidtear chun cógais chríochnaithe a tháirgeadh agus a mhonarú, táthar tar éis táirgí áirithe as measc na dtáirgí idirmheánacha sin a aistriú go liosta na n-ANInna, agus táthar tar éis cur le liosta na réimíreanna agus na n-iarmhíreanna sonraithe le haghaidh salann, eistear nó hiodráití d'ANInna.

(5) Measadh gurbh iomchuí an ceathrú hathbhreithniú a dhéanamh agus cuireadh tús leis an athbhreithniú sin in 2009. Baineadh de thátal as gur cheart déileáil ar bhonn saor ó dhleacht le líon áirithe ANInna breise agus le líon áirithe táirgí idirmheánacha cógaisíochta a úsáidtear chun cógais chríochnaithe a tháirgeadh agus a mhonarú, gur cheart táirgí áirithe de na táirgí idirmheánacha a áiríodh cheana a aistriú go liosta na n-ANInna, agus gur cheart cur le liosta na réimíreanna agus na n-iarmhíreanna sonraithe le haghaidh salann, eistear nó hiodráití d'ANInna.

(6) Le Rialachán (CEE) ón gComhairle Uimh. 2658/87 an 23 Iúil 1987 maidir leis an ainmníocht taraife agus staidrimh agus leis an gComhtharaif Chustaim[1] bunaíodh an Ainmníocht Chomhcheangailte (AC) agus leagadh amach rátaí dleachta coinbhinsiúnta na Comhthairife Custaim.

(7) Dá bhrí sin, ba chóir Rialachán (CEE) Uimh. 2658/87 a leasú dá réir sin.

(8) (Ionas go n-áiritheofar go mbeidh na bearta dá bhforáiltear sa Rialachán seo i bhfeidhm ar an 1 Eanáir 2011, ba cheart go dtiocfadh sé i bhfeidhm an lá tar éis lá a fhoilsithe.]

TAR ÉIS AN RIALACHÁN SEO A GHLACADH:

Airteagal 1

Ón 1 Eanáir 2011 i leith déileálfaidh an tAontas Eorpach ar bhonn saor ó dhleacht leis na ANInna a liostaítear in Iarscríbhinn I.

Airteagal 2

Ón 1 Eanáir 2011, maidir le liosta na réimíreanna agus na n-iarmhíreanna lena dtuairiscítear, i gcomhcheangal leis na ANInna atá ar áireamh, salainn, eistir nó hiodráití d'ANInna ar féidir déileáil leo freisin ar bhonn saor ó dhleacht, ar choinníoll gur féidir iad a aicmiú faoin bhfo-cheannteideal CC sé dhigit céanna leis an ANI comhfhreagrach, déanfar an liosta a leasú mar a leagtar amach in Iarscríbhinn II.

Airteagal 3

Ón 1 Eanáir 2011 déileálfaidh an tAontas Eorpach ar bhonn saor ó dhleacht freisin leis na táirgí idirmheánacha cógaisíochta a úsáidtear chun cógais chríochnaithe a tháirgeadh agus a mhonarú agus a liostaítear in Iarscríbhinn III.

Airteagal 4

Ón 1 Eanáir 2011 déanfar na táirgí idirmheánacha cógaisíochta a liostaítear in Iarscríbhinn IV a bhaint ó liosta na gcomhdhúl sin a ndéileáiltear leo ar bhonn saor ó dhleacht.

Airteagal 5

Déanfar Iarscríbhinní 3, 4 agus 6 de Roinn II de Chuid a trí d'Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87 (Liostaí substaintí cógaisíochta ar féidir déileáil leo ar bhonn saor ó dhleacht), a leasú dá réir.

Airteagal 6

Tiocfaidh an Rialachán seo i bhfeidhm an lá tar éis lá a fhoilsithe in Iris Oifigiúil an Aontais Eorpaigh.

Beidh an Rialachán seo ina cheangal go huile agus go hiomlán agus beidh sé infheidhme go díreach i ngach Ballstát.

Arna dhéanamh sa Bhruiséil, an […]

Thar ceann Pharlaimint na hEorpa Thar ceann na Comhairle

An tUachtarán An tUachtarán […] […]

IARSCRÍBHINN I

Liosta ainmneacha neamhdhílseánacha idirnáisiúnta (ANInna) le cur le liosta na dtáirgí a ndéileáiltear leo ar bhonn saor ó dhleacht agus atá ar áireamh in Iarscríbhinn 3 d'Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87

Cód AC | Uimh. CAS RN | Ainm |

2842 90 80 | 119175-48-3 | fermagate |

2843 90 90 | 759457-82-4 | padeliporfin |

2844 40 30 | 123748-56-1 | iodofiltic acid (123I) |

2904 10 00 | 21668-77-9 | eprodisate |

2906 19 00 | 199798-84-0 | elocalcitol |

2909 30 90 | 24150-24-1 | terameprocol |

2916 19 95 | 81485-25-8 | peretinoin |

2916 39 00 | 51543-40-9 | tarenflurbil |

2918 19 98 | 174022-42-5 | bevirimat |

2919 90 00 | 258516-89-1 | fospropofol |

2920 90 85 | 163133-43-5 | naproxcinod |

2921 19 99 | 3687-18-1 | tramiprosate |

2922 19 85 | 68392-35-8 | afimoxifene |

2922 19 85 | 753449-67-1 | ronacaleret |

2922 29 00 | 433265-65-7 | faxeladol |

2922 50 00 | 121524-08-1 | Amibegron |

2922 50 00 | 329773-35-5 | Cinaciguat |

2922 50 00 | 643094-49-9 | fasobegron |

2923 10 00 | 856676-23-8 | choline fenofibrate |

2924 29 98 | 847353-30-4 | arbaclofen placarbil |

2924 29 98 | 194785-19-8 | bedoradrine |

2924 29 98 | 194085-75-1 | Carisbamate |

2924 29 98 | 254750-02-2 | emricasan |

2924 29 98 | 355129-15-6 | eprotirome |

2924 29 98 | 402567-16-2 | firategrast |

2924 29 98 | 478296-72-9 | gabapentin enacarbil |

2924 29 98 | 15866-90-7 | incyclinide |

2924 29 98 | 202844-10-8 | indantadol |

2924 29 98 | 96847-55-1 | levomilnacipran |

2924 29 98 | 608137-32-2 | lisdexamfetamine |

2924 29 98 | 652990-07-3 | milveterol |

2924 29 98 | 181816-48-8 | ombrabulin |

2924 29 98 | 289656-45-7 | senicapoc |

2925 19 95 | 19171-19-8 | pomalidomide |

2928 00 90 | 22033-87-0 | olesoxime |

2928 00 90 | 2675-35-6 | sivifene |

2928 00 90 | 816458-31-8 | tecovirimat |

2928 00 90 | 238750-77-1 | tosedostat |

2928 00 90 | 149647-78-9 | vorinostat |

2929 90 00 | 31645-39-3 | palifosfamide |

2930 90 99 | 608141-41-9 | apremilast |

2930 90 99 | 216167-92-9 | camobucol |

2930 90 99 | 211513-37-0 | dalcetrapib |

2930 90 99 | 69819-86-9 | Darinaparsin |

2930 90 99 | 488832-69-5 | elesclomol |

2930 90 99 | 216167-95-2 | elsibucol |

2930 90 99 | 168682-53-9 | ezatiostat |

2930 90 99 | 58569-55-4 | metenkefalin |

2930 90 99 | 887148-69-8 | Monepantel |

2930 90 99 | 603139-19-1 | odanacatib |

2930 90 99 | 162520-00-5 | salirasib |

2930 90 99 | 216167-82-7 | succinobucol |

2930 90 99 | 125961-82-2 | tipelukast |

2931 00 99 | 125973-56-0 | amsilarotene |

2932 19 00 | 253128-41-5 | eribulin |

2932 19 00 | 186953-56-0 | pafuramidine |

2932 29 85 | 195883-06-8 | Omtriptolide |

2932 99 00 | 664338-39-0 | arterolane |

2932 99 00 | 183133-96-2 | cabazitaxel |

2932 99 00 | 401925-43-7 | celivarone |

2932 99 00 | 461432-26-8 | dapagliflozin |

2932 99 00 | 118457-15-1 | dexnebivolol |

2932 99 00 | 156294-36-9 | larotaxel |

2932 99 00 | 118457-16-2 | levonebivolol |

2932 99 00 | 83461-56-7 | Mifamurtide |

2932 99 00 | 117570-53-3 | vadimezan |

2933 19 90 | 496775-61-2 | eltrombopag |

2933 19 90 | 206884-98-2 | niraxostat |

2933 19 90 | 410528-02-8 | palovarotene |

2933 19 90 | 376592-42-6 | totrombopag |

2933 29 90 | 183659-72-5 | catramilast |

2933 29 90 | 944263-65-4 | demiditraz |

2933 29 90 | 867153-61-5 | dulanermin |

2933 29 90 | 320367-13-3 | lixisenatide |

2933 29 90 | 698389-00-3 | rolipoltide |

2933 29 90 | 697766-75-9 | velafermin |

2933 39 99 | 147084-10-4 | alcaftadine |

2933 39 99 | 54-96-6 | Amifampridine |

2933 39 99 | 249921-19-5 | anamorelin |

2933 39 99 | 319460-85-0 | axitinib |

2933 39 99 | 208110-64-9 | befiradol |

2933 39 99 | 330942-05-7 | betrixaban |

2933 39 99 | 201034-75-5 | daporinad |

2933 39 99 | 209783-80-2 | entinostat |

2933 39 99 | 412950-27-7 | goxalapladib |

2933 39 99 | 218791-21-0 | imisopasem manganese |

2933 39 99 | 103129-82-4 | levamlodipine |

2933 39 99 | 154357-42-3 | levonadifloxacin |

2933 39 99 | 108147-54-2 | migalastat |

2933 39 99 | 453562-69-1 | motesanib |

2933 39 99 | 139145-27-0 | parogrelil |

2933 39 99 | 459856-18-9 | pexacerfont |

2933 39 99 | 706779-91-1 | pimavanserin |

2933 39 99 | 362665-56-3 | Pitolisant |

2933 39 99 | 861151-12-4 | rosonabant |

2933 39 99 | 701977-09-5 | taranabant |

2933 39 99 | 189950-11-6 | tropantiol |

2933 39 99 | 793655-64-8 | Vapitadine |

2933 39 99 | 139290-65-6 | volinaserin |

2933 49 90 | 141388-76-3 | besifloxacin |

2933 49 90 | 697761-98-1 | elvitegravir |

2933 49 90 | 185055-67-8 | ferroquine |

2933 49 90 | 445041-75-8 | intiquinatine |

2933 49 90 | 378746-64-6 | nemonoxacin |

2933 49 90 | 245765-41-7 | ozenoxacin |

2933 49 90 | 412950-08-4 | rilapladib |

2933 49 90 | 871224-64-5 | almorexant |

2933 49 90 | 863029-99-6 | balamapimod |

2933 49 90 | 698387-09-6 | neratinib |

2933 49 90 | 154652-83-2 | tezampanel |

2933 49 90 | 128253-31-6 | veliflapon |

2933 59 95 | 791828-58-5 | aderbasib |

2933 59 95 | 840486-93-3 | Adipiplon |

2933 59 95 | 850649-61-5 | Alogliptin |

2933 59 95 | 859212-16-1 | Bafetinib |

2933 59 95 | 380843-75-4 | Bosutinib |

2933 59 95 | 839712-12-8 | cariprazine |

2933 59 95 | 414910-27-3 | casopitant |

2933 59 95 | 288383-20-0 | cediranib |

2933 59 95 | 849550-05-6 | cevipabulin |

2933 59 95 | 827318-97-8 | danusertib |

2933 59 95 | 356057-34-6 | darapladib |

2933 59 95 | 501000-36-8 | dutacatib |

2933 59 95 | 247257-48-3 | fimasartan |

2933 59 95 | 3432-99-3 | folitixorin |

2933 59 95 | 668270-12-0 | linagliptin |

2933 59 95 | 441798-33-0 | macitentan |

2933 59 95 | 641571-10-0 | Nilotinib |

2933 59 95 | 763113-22-0 | Olaparib |

2933 59 95 | 686344-29-6 | otenabant |

2933 59 95 | 625115-55-1 | riociguat |

2933 59 95 | 486460-32-6 | sitagliptin |

2933 59 95 | 425637-18-9 | sotrastaurin |

2933 59 95 | 309913-83-5 | talmapimod |

2933 59 95 | 113857-87-7 | talotrexin |

2933 59 95 | 274693-27-5 | ticagrelor |

2933 59 95 | 306296-47-9 | vicriviroc |

2933 69 80 | 775351-65-0 | imeglimin |

2933 79 00 | 461443-59-4 | aplaviroc |

2933 79 00 | 189691-06-3 | bremelanotide |

2933 79 00 | 813452-18-5 | carmegliptin |

2933 79 00 | 405169-16-6 | dovitinib |

2933 79 00 | 536748-46-6 | eribaxaban |

2933 79 00 | 473289-62-2 | ilepatril |

2933 79 00 | 180694-97-7 | mimopezil |

2933 79 00 | 579475-18-6 | orvepitant |

2933 79 00 | 449811-01-2 | pamapimod |

2933 79 00 | 248282-01-1 | paquinimod |

2933 79 00 | 380917-97-5 | perampanel |

2933 79 00 | 552292-08-7 | rolapitant |

2933 79 00 | 425386-60-3 | semagacestat |

2933 79 00 | 515814-01-4 | voclosporin |

2933 99 80 | 481629-87-2 | aleplasinin |

2933 99 80 | 394730-60-0 | boceprevir |

2933 99 80 | 649735-63-7 | brivanib alaninate |

2933 99 80 | 483369-58-0 | denagliptin |

2933 99 80 | 284019-34-7 | denibulin |

2933 99 80 | 481631-45-2 | diaplasinin |

2933 99 80 | 272105-42-7 | disitertide |

2933 99 80 | 227318-71-0 | epetirimod |

2933 99 80 | 259793-96-9 | favipiravir |

2933 99 80 | 871576-03-3 | flovagatran |

2933 99 80 | 229305-39-9 | golotimod |

2933 99 80 | 258818-34-7 | larazotide |

2933 99 80 | 571170-77-9 | laropiprant |

2933 99 80 | 616202-92-7 | lorcaserin |

2933 99 80 | 868771-57-7 | melogliptin |

2933 99 80 | 803712-67-6 | obatoclax |

2933 99 80 | 404950-80-7 | panobinostat |

2933 99 80 | 625114-41-2 | piragliatin |

2933 99 80 | 74847-35-1 | pyronaridine |

2933 99 80 | 872178-65-9 | rabeximod |

2933 99 80 | 355151-12-1 | rotigaptide |

2933 99 80 | 497221-38-2 | rusalatide |

2933 99 80 | 187602-11-5 | sofigatran |

2933 99 80 | 227318-75-4 | sotirimod |

2933 99 80 | 402957-28-2 | telaprevir |

2933 99 80 | 848084-83-3 | tigapotide |

2933 99 80 | 393105-53-8 | tiplasinin |

2933 99 80 | 620948-93-8 | vabicaserin |

2933 99 80 | 794466-70-9 | vernakalant |

2934 10 00 | 544417-40-5 | Capadenoson |

2934 10 00 | 302962-49-8 | dasatinib |

2934 10 00 | 223132-37-4 | inolitazone |

2934 10 00 | 241479-67-4 | isavuconazole |

2934 10 00 | 338990-84-4 | isavuconazonium chloride |

2934 10 00 | 607723-33-1 | lobeglitazone |

2934 10 00 | 280782-97-0 | managlinat dialanetil |

2934 10 00 | 790299-79-5 | masitinib |

2934 10 00 | 223673-61-8 | mirabegron |

2934 10 00 | 501948-05-6 | rosabulin |

2934 10 00 | 447406-78-2 | sodelglitazar |

2934 10 00 | 760937-92-6 | teneligliptin |

2934 20 80 | 848344-36-5 | Bentamapimod |

2934 20 80 | 870093-23-5 | talarozole |

2934 99 90 | 320345-99-1 | aclidinium bromide |

2934 99 90 | 222551-17-9 | adoprazine |

2934 99 90 | 207623-20-9 | agatolimod |

2934 99 90 | 475479-34-6 | aleglitazar |

2934 99 90 | 870524-46-2 | amolimogene bepiplasmid |

2934 99 90 | 875446-37-0 | anacetrapib |

2934 99 90 | 250386-15-3 | apadenoson |

2934 99 90 | 541550-19-0 | apilimod |

2934 99 90 | 160707-69-7 | apricitabine |

2934 99 90 | 147403-03-0 | azilsartan |

2934 99 90 | 863031-21-4 | azilsartan medoxomil |

2934 99 90 | 757942-43-1 | bederocin |

2934 99 90 | 627861-07-8 | beperminogene perplasmid |

2934 99 90 | 959961-96-7 | bevasiranib |

2934 99 90 | 769901-96-4 | capeserod |

2934 99 90 | 868540-17-4 | carfilzomib |

2934 99 90 | 872847-66-0 | cenersen |

2934 99 90 | 80295-38-1 | conestat alfa |

2934 99 90 | 903916-27-8 | custirsen |

2934 99 90 | 187865-22-1 | derquantel |

2934 99 90 | 134379-77-4 | dexelvucitabine |

2934 99 90 | 247046-52-2 | dilopetine |

2934 99 90 | 480449-70-5 | edoxaban |

2934 99 90 | 188181-42-2 | elacytarabine |

2934 99 90 | 98819-76-2 | esreboxetine |

2934 99 90 | 763903-67-9 | fosalvudine tidoxil |

2934 99 90 | 172673-20-0 | fosaprepitant |

2934 99 90 | 522664-63-7 | ibodutant |

2934 99 90 | 405159-59-3 | idrabiotaparinux sodium |

2934 99 90 | 188116-07-6 | imepitoin |

2934 99 90 | 335619-18-6 | inakalant |

2934 99 90 | 1391-36-2 | lancovutide |

2934 99 90 | 189059-71-0 | lapaquistat |

2934 99 90 | 327026-93-7 | lensiprazine |

2934 99 90 | 170632-47-0 | lificiguat |

2934 99 90 | 852313-25-8 | litenimod |

2934 99 90 | 1000120-98-8 | mipomersen |

2934 99 90 | 62253-63-8 | nepidermin |

2934 99 90 | 26833-87-4 | omacetaxine mepesuccinate |

2934 99 90 | 269718-84-5 | pardoprunox |

2934 99 90 | 219923-85-0 | Pramiconazole |

2934 99 90 | 377727-87-2 | preladenant |

2934 99 90 | 524684-52-4 | prinaberel |

2934 99 90 | 865311-47-3 | quarfloxin |

2934 99 90 | 869884-78-6 | radezolid |

2934 99 90 | 496054-87-6 | radiprodil |

2934 99 90 | 518048-05-0 | raltegravir |

2934 99 90 | 787548-03-2 | regrelor |

2934 99 90 | 820957-38-8 | Retosiban |

2934 99 90 | 572924-54-0 | Ridaforolimus |

2934 99 90 | 128517-07-7 | romidepsin |

2934 99 90 | 93265-81-7 | Ropidoxuridine |

2934 99 90 | 151823-14-2 | sapacitabine |

2934 99 90 | 379231-04-6 | saracatinib |

2934 99 90 | 791635-59-1 | simotaxel |

2934 99 90 | 119567-79-2 | taribavirin |

2934 99 90 | 332012-40-5 | telatinib |

2934 99 90 | 925681-61-4 | trabedersen |

2934 99 90 | 189003-92-7 | trelanserin |

2934 99 90 | 296251-72-4 | velimogene aliplasmid |

2934 99 90 | 904302-98-3 | viquidacin |

2934 99 90 | 872525-61-6 | votucalis |

2934 99 90 | 221877-54-9 | zotarolimus |

2935 00 90 | 197904-84-0 | apricoxib |

2935 00 90 | 769169-27-9 | begacestat |

2935 00 90 | 414864-00-9 | belinostat |

2935 00 90 | 313682-08-5 | brecanavir |

2935 00 90 | 839673-52-8 | cevoglitazar |

2935 00 90 | 358970-97-5 | drinabant |

2935 00 90 | 865200-20-0 | giripladib |

2935 00 90 | 464213-10-3 | ibipinabant |

2935 00 90 | 173424-77-6 | laromustine |

2935 00 90 | 398507-55-6 | lodenafil carbonate |

2935 00 90 | 136564-68-6 | masilukast |

2935 00 90 | 170569-88-7 | mavacoxib |

2935 00 90 | 862189-95-5 | mirodenafil |

2935 00 90 | 439687-69-1 | nelivaptan |

2935 00 90 | 691852-58-1 | nesbuvir |

2935 00 90 | 778576-62-8 | oglemilast |

2935 00 90 | 444731-52-6 | pazopanib |

2935 00 90 | 362505-84-8 | relacatib |

2935 00 90 | 243984-11-4 | resatorvid |

2935 00 90 | 519055-62-0 | tasisulam |

2935 00 90 | 186497-07-4 | zibotentan |

2936 29 00 | 104121-92-8 | Eldecalcitol |

2936 29 00 | 31690-09-2 | levomefolic acid |

2937 19 00 | 782500-75-8 | albiglutide |

2937 19 00 | 348119-84-6 | obinepitide |

2937 19 00 | 295350-45-7 | ozarelix |

2937 19 00 | 275371-94-3 | taspoglutide |

2937 19 00 | 218949-48-5 | tesamorelin |

2937 19 00 | 22006-64-0 | tridecactide |

2937 22 00 | 132245-57-9 | dexamethasone cipecilate |

2937 22 00 | 397864-44-7 | fluticasone furoate |

2937 29 00 | 211254-73-8 | Lonaprisan |

2937 50 00 | 333963-42-1 | cobiprostone |

2937 50 00 | 172740-14-6 | posaraprost |

2937 90 00 | 834153-87-6 | elagolix |

2937 90 00 | 609799-22-6 | tasimelteon |

2937 90 00 | 342577-38-2 | velneperit |

2939 19 00 | 73232-52-7 | methylnaltrexone bromide |

2939 59 00 | 136199-02-5 | rolofylline |

2939 99 00 | 850607-58-8 | darotropium bromide |

2939 99 00 | 187852-63-7 | Delimotecan |

2940 00 00 | 9007-72-1 | ferric carboxymaltose |

2940 00 00 | 442201-24-3 | remogliflozin etabonate |

2940 00 00 | 408504-26-7 | sergliflozin etabonate |

2941 90 00 | 467214-20-6 | Alvespimycin |

2941 90 00 | 677017-23-1 | Berubicin |

2941 90 00 | 229016-73-3 | ceftaroline fosamil |

2941 90 00 | 318498-76-9 | flopristin |

2941 90 00 | 145435-72-9 | Gamithromycin |

2941 90 00 | 325965-23-9 | linopristin |

2941 90 00 | 857402-23-4 | retaspimycin |

2941 90 00 | 305841-29-6 | sagopilone |

2941 90 00 | 75747-14-7 | Tanespimycin |

2941 90 00 | 328898-40-4 | tildipirosin |

2941 90 00 | 222400-20-6 | tomopenem |

2941 90 00 | 63409-12-1 | tylvalosin |

3001 90 91 | 9041-08-1 | semuloparin sodium |

3002 10 91 | 792921-10-9 | abagovomab |

3002 10 91 | 910649-32-0 | anrukinzumab |

3002 10 91 | 648904-28-3 | bavituximab |

3002 10 91 | 402710-27-4 (light chain) 402710-25-2 (heavy chain) | canakinumab |

3002 10 99 | 945228-49-9 | citatuzumab bogatox |

3002 10 91 | 880486-59-9 | dacetuzumab |

3002 10 91 | 615258-40-7 | denosumab |

3002 10 91 | 762260-74-2 | efungumab |

3002 10 91 | 89957-37-9 | gantenerumab |

3002 10 91 | 680188-33-4 | ibalizumab |

3002 10 91 | 477202-00-9 | ipilimumab |

3002 10 91 | 640735-09-7 | iratumumab |

3002 10 91 | 845816-02-6 | lexatumumab |

3002 10 91 | 903512-50-5 | lucatumumab |

3002 10 91 | 899796-83-9 | milatuzumab |

3002 10 91 | 677010-34-3 | motavizumab |

3002 10 91 | 676258-98-3 | naptumomab estafenatox |

3002 10 91 | 828933-51-3 | nimotuzumab |

3002 10 91 | 949142-50-1 | Obinutuzumab |

3002 10 91 | 637334-45-3 | ocrelizumab |

3002 10 91 | 881191-44-2 | otelixizumab |

3002 10 91 | 372075-37-1 | sontuzumab |

3002 10 91 | 705287-60-1 | stamulumab |

3002 10 91 | 339086-80-5 | tadocizumab |

3002 10 91 | 592557-43-2 (light chain) 592557-41-0 (heavy chain) | Tenatumomab |

3002 10 91 | 876387-05-2 | teplizumab |

3002 10 91 | 918127-53-4 | tigatuzumab |

3002 10 91 | 745013-59-6 | Tremelimumab |

3002 10 91 | 339986-90-2 | tucotuzumab celmoleukin |

3002 10 91 | 728917-18-8 | veltuzumab |

3002 10 91 | 896731-82-1 | conatumumab |

3002 10 91 | 892553-42-3 | etaracizumab |

3002 10 91 | 944548-38-3 | foravirumab |

3002 10 91 | 944548-37-2 | rafivirumab |

3002 10 91 | 880266-57-9 | tanezumab |

3002 10 91 | 815610-63-0 | ustekinumab |

3002 10 95 | 862111-32-8 | aflibercept |

3002 10 95 | 845264-92-8 | atacicept |

3002 10 95 | 909110-25-4 | baminercept |

3002 10 95 | 9001-27-8 | beroctocog alfa |

3002 10 95 | 879555-13-2 | epoetin kappa |

3002 10 95 | 762263-14-9 | epoetin theta |

3002 10 95 | 501081-76-1 | rilonacept |

3002 10 95 | 267639-76-9 | romiplostim |

3002 10 95 | 869858-13-9 | thrombin alfa |

3002 10 95 | 897936-89-9 | vatreptacog alfa (activated) |

3002 10 95 | 472960-22-8 | albinterferon alfa-2b |

3002 10 95 | 869881-54-9 | briobacept |

3002 10 95 | 606138-08-3 | catridecacog |

3002 10 95 | 716840-32-3 | denenicokin |

3002 10 95 | 931101-84-7 | troplasminogen alfa |

3002 10 99 | 934216-54-3 | alacizumab pegol |

3002 20 00 | 181477-43-0 | disomotide |

3002 20 00 | 181477-91-8 | ovemotide |

3002 20 00 | 915019-08-8 | tertomotide |

3002 20 00 | 295371-00-5 | verpasep caltespen |

3002 90 90 | 473553-86-5 | Alferminogene tadenovec |

3002 90 90 | 929881-05-0 | alipogene tiparvovec |

3002 90 90 | 600735-73-7 | contusugene ladenovec |

3002 90 90 | 851199-59-2 | Linaclotide |

3002 90 90 | 898830-54-1 | sitimagene ceradenovec |

3002 90 90 | 721946-42-5 | transferrin aldifitox |

3507 90 90 | 9026-00-0 | bucelipase alfa |

3507 90 90 | 885051-90-1 | pegloticase |

3507 90 90 | 884604-91-5 | velaglucerase alfa |

3911 90 99 | 892497-01-7 | azoximer bromide |

IARSCRÍBHINN II

Liosta na réimíreanna agus na n-iarmhíreanna lena dtuairiscítear, i gcomhcheangal le ANInna Iarscríbhinn 3 d'Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87, salainn, eistir nó hiodráití d'ANInna; tá na salainn, eistir agus hiodráití sin saor ó dhleacht, ar choinníoll gur féidir iad a aicmiú faoin bhfo-cheannteideal CC sé dhigit céanna leis an ANI comhfhreagrach.

In ionad na dtagairtí do "Ainmneacha Neamhdhílseánacha Idirnáisiúnta (ANI) do shubstaintí cógaisíochta, Ainmneacha d'fhréamhacha agus do ghrúpaí, liosta cuimsitheach 2004" cuirtear "Ainmneacha Neamhdhílseánacha Idirnáisiúnta (ANI) do shubstaintí cógaisíochta, Ainmneacha d'fhréamhacha, do ghrúpaí agus eile, liosta cuimsitheach 2007".

Cuirtear na réimíreanna agus na hiarmhíreanna seo a leanas leis an liosta:

An réimír nó an iarmhír is fearr | Comhchiallach | Ainm córasach nuair atá sé éagsúil |

alanetil (INNRG) | [(S)-1-ethoxy-1-oxo-propan-2-yl]amino (INNCN) |

alaninate (INNRG) | L-alaninate (INNCN) |

alapivoxil (INNRG) | L-alanyl, [(2,2-dimethylpropanoyl)oxy]methyl (INNCN) |

aldifitox (INNRG) | (4-iminobutane-1,4-diyl)sulfanediyl[(3RS)-2,5-dioxopyrrolidine-1,3-diyl]-1,3-phenylenecarbonyl agus a dhéanann díorthach N-beansóil de phríomhghrúpa aimín de thocsain diftéire [550-L-phenylalanine] ó Corynebacterium diphtheriae-(26-560)-peptide (INNCN) |

besudotox (INNRG) | Leáphróitéin L-lysyl-L-alanyl-L-serylglycylglycine (nascóir) le des-(365-380)-[Asn364,Val407,Ser515,Gln590,Gln606,Arg613]exotoxin A (Pseudomonas aeruginosa)-(251-613)-peptide (tocsain inar scriosadh iarmhair réigiún IA agus na chéad 16 iarmhar réigiún IB) (INNCN) |

ceribate (INNRG) | rac-2,3-dihydroxypropyl carbonate (eistear) (INNCN) |

cipecilate (INNRG) | cyclohexanecarboxylate (eistear), cyclopropanecarboxylate (eistear) (INNCN) |

dalanated (INNRG) | des-B30-alanine (INNCN) |

enacarbil (INNRG) | {rac-1-[(2-methylpropanoyl)oxy]ethoxy}carbonyl (INNCN) |

estafenatox (INNRG) | Leáphróitéin glycylglycyl-L-proline (nascóir) le enterotoxin de chineál A (Staphylococcus aureus)-(1-33)-peptidyl-L-seryl[Ser36,Ser37,Glu38,Lys39,Ala41,Thr46,Thr71,Ala72,Ser75,Glu76,Glu78,Ser80,Ser81,Thr214,Ser217,Thr219,Ser220,Ser222,Ser224]enterotoxin type E (Staphylococcus aureus)-(32-230)-peptide (sár-antaigin shintéiseach SEA/E-120) (INNCN) |

etexilate (INNRG) | ethyl, (hexyloxy)carbonyl |

fosamil (INNRG) | phosphono (INNCN) |

glucuronide (INNRG) | β-D-glucopyranosiduronic acid [oside] (INNCN) |

medocaril (INNRG) | [(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy]carbonyl (INNCN) |

paptox (INNRG) | próitéin PAP (Phytolacca americana frith-víreach) (INNCN) |

placarbil (INNRG) | (R)-2-methyl-1-[(2-methylpropanoyl)oxy]propoxy}carbonyl) (INNCN) |

Leasaítear ainm córasach na réimíre nó na hiarmhíre seo a leanas mar seo a leanas:

An réimír nó an iarmhír is fearr | Comhchiallach | Ainm córasach nuair atá sé éagsúil |

aritox (INNRG) | ricin A chain (INNCN) |

IARSCRÍBHINN III

Liosta táirgí idirmheánacha cógaisíochta, i.e. comhdhúile a úsáidtear chun táirgí críochnaithe cógaisíochta a mhonarú, atá le cur le liosta na dtáirgí a ndéileáiltear leo ar bhonn saor ó dhleacht agus atá ar áireamh in Iarscríbhinn 6 d'Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87

ID | Cód AC | Uimh. CAS RN | Ainm |

95 | 2843 29 00 | 22199-08-2 | [4-amino-N-(pyrimidin-2(1H)-ylidene-κN1)benzenesulfonamidato-κO]airgead |

428 | 2905 39 95 | 281214-27-5 | (2R,3R)-2,3-dimethylbutane-1,4-diyl bis(4-methylbenzenesulfonate) |

76 | 2905 59 98 | 441002-17-1 | 4-chlorobutyl 2-nitrobenzenesulfonate |

538 | 2909 30 90 | 92878-95-0 | 2-(3-chloropropoxy)-1-methoxy-4-nitrobenzene |

168 | 2909 30 | 503070-57-3 | 2-({2-[(6-bromohexyl)oxy]ethoxy}methyl)-1,3-dichlorobenzene |

386 | 2909 30 | 461432-23-5 | 4-(5-bromo-2-chlorobenzyl)phenyl ethyl ether |

51 | 2909 49 80 | 185954-75-0 | (3R)-3-methoxydecan-1-ol |

167 | 2909 49 80 | 85309-91-7 | 2-[(2,6-dichlorobenzyl)oxy]ethanol |

64 | 2909 49 80 | 160969-03-9 | 2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl methanesulfonate |

98 | 2909 50 00 | 167145-13-3 | 2-[2-(3-methoxyphenyl)ethyl]phenol |

377 | 2910 20 00 | 15448-47-2 | (2R)-2-methyloxirane |

177 | 2910 90 00 | 62600-71-9 | (2R)-2-(3-chlorophenyl)oxirane |

184 | 2910 90 00 | 702687-42-1 | (2R)-2-[(5-bromo-2,3-difluorophenoxy)methyl]oxirane |

88 | 2910 90 00 | 683276-64-4 | [(2R)-2-methyloxiran-2-yl]methyl 4-nitrobenzenesulfonate |

191 | 2913 00 00 | 90035-34-0 | 4'-(trifluoromethyl)biphenyl-4-carbaldehyde |

38 | 2914 40 90 | 17752-16-8 | (3β)-3-hydroxycholest-5-en-24-one |

244 | 2914 50 00 | 974-23-2 | (3β,16α)-3-hydroxy-16,17-epoxypregn-5-en-20-one |

586 | 2914 70 00 | 13054-81-4 | 4-chloro-heptane-3,5-dione |

236 | 2914 70 00 | 10226-30-9 | 6-chlorohexan-2-one |

122 | 2915 60 90 | 53064-79-2 | iodomethyl pivalate |

426 | 2915 90 00 | 22328-90-1 | (3R)-3-methylhexanoic acid |

266 | 2915 90 00 | 1069-66-5 | sodium 2-propylpentanoate |

19 | 2916 20 00 | 211515-46-7 | 1-(2-ethylbutyl)cyclohexanecarbonyl chloride |

32 | 2916 20 00 | 381209-09-2 | 1-(2-ethylbutyl)cyclohexanecarboxylic acid |

37 | 2916 20 00 | 7077-05-6 | trans-4-(propan-2-yl)cyclohexanecarboxylic acid |

531 | 2916 39 00 | 21900-39-0 | 5-fluoro-2-methylbenzoyl chloride |

250 | 2916 39 00 | 17625-03-5 | sodium hydrogen 3-sulfonatobenzoate |

561 | 2917 19 90 | 76-72-2 | diethyl ethyl(pentan-2-yl)propanedioate |

193 | 2918 29 00 | 376592-58-4 | 5'-chloro-2'-hydroxy-3'-nitrobiphenyl-3-carboxylic acid |

369 | 2918 99 90 | 709031-28-7 | (3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)acetic acid |

552 | 2918 99 90 | 35480-52-5 | 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid |

559 | 2918 99 90 | 4651-67-6 | (3α,5β)-3-hydroxy-7-oxocholan-24-oic acid |

264 | 2918 99 90 | 52179-28-9 | ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoate |

143 | 2918 99 90 | 530141-60-7 | methyl 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-hydroxyphenyl)propanoate |

114 | 2920 90 10 | 91526-18-0 | 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one |

161 | 2921 49 00 | 334477-60-0 | (1R)-1-[3,5-bis(trifluoromethyl)phenyl]-N-methylethanamine |

287 | 2921 49 00 | 376608-71-8 | (1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate |

342 | 2921 49 00 | 1034457-07-2 | 2-(2,3-dihydro-1H-inden-2-yl)propan-2-amine hydrochloride |

27 | 2921 49 00 | 945717-05-5 | 2-(4-chloro-3-ethylphenyl)ethanamine hydrochloride |

221 | 2921 49 00 | 89-97-4 | 2-chlorobenzylamine |

26 | 2921 49 00 | 945717-43-1 | N-(4-tert-butylbenzyl)-2-(4-chloro-3-ethylphenyl)ethanamine |

518 | 2921 51 90 | 150812-21-8 | N4-[(4-fluorophenyl)methyl]-2-nitro-1,4-benzenediamine |

343 | 2922 19 80 | 1035455-90-3 | (2R)-1-(5-bromo-2,3-difluorophenoxy)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2- yl]amino}propan-2-ol hydrochloride |

397 | 2922 19 80 | 0-00-0 | [2-(chloromethyl)-4-(dibenzylamino)phenyl]methanol hydrochloride |

248 | 2922 19 80 | 133-51-7 | antimonic acid -- 1-deoxy-1-(methylamino)-D-glucitol (1:1) |

344 | 2922 19 80 | 1035455-87-8 | ethyl (2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl)prop-2-enoate hydrochloride |

185 | 2922 19 80 | 702686-97-3 | ethyl 3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-4,5-difluorophenyl)propanoate hydrochloride |

36 | 2922 29 00 | 20059-73-8 | 2-[4-(aminomethyl)phenoxy]-N,N-dimethylethanamine |

536 | 2922 49 85 | 848133-35-7 | (2E)-4-(dimethylamino)but-2-enoic acid hydrochloride |

425 | 2922 49 85 | 610300-07-7 | (3S,5R)-3-amino-5-methyloctanoic acid |

424 | 2922 49 85 | 610300-00-0 | (3S,5R)-3-amino-5-methyloctanoic acid hydrochloride |

433 | 2922 49 85 | 143785-86-8 | 4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid |

398 | 2922 49 85 | 848949-85-9 | 4-fluoro-L-leucine -- ethyl hydrogen sulfate (1:1) |

475 | 2922 49 85 | 39068-93-4 | methyl 2-(dimethylamino)-2-phenylbutanoate |

174 | 2922 49 85 | 168619-25-8 | methyl 3'-aminobiphenyl-3-carboxylate |

565 | 2922 49 85 | 82834-12-6 | N-[(2S)-1-ethoxy-1-oxopentan-2-yl]-L-alanine |

474 | 2922 49 85 | 94133-84-3 | sodium 2-amino-2-phenylbutanoate |

171 | 2922 50 00 | 503070-58-4 | triphenylacetic acid -- 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1) |

149 | 2924 19 00 | 62009-47-6 | 2-aminomalonamide |

175 | 2924 19 00 | 7355-58-0 | N-(2-chloroethyl)acetamide |

367 | 2924 29 98 | 361442-00-4 | {2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl}acetic acid |

521 | 2924 29 98 | 266993-72-0 | 2,3-diaminobenzamide dihydrochloride |

532 | 2924 29 98 | 168080-49-7 | 2-chloro-4-{[(5-fluoro-2-methylphenyl)carbonyl]amino}benzoic acid |

81 | 2924 29 98 | 317374-08-6 | 2-methyl-4-{[(2-methylphenyl)carbonyl]amino}benzoic acid |

125 | 2924 29 98 | 143785-84-6 | 4-(1-carbamoylcyclopropyl)-2,3,5-trifluorobenzoic acid |

434 | 2924 29 98 | 143785-87-9 | 4-[1-(acetylamino)cyclopropyl]-2,3,5-trifluorobenzoic acid |

80 | 2924 29 98 | 108166-22-9 | 4-{[(2-methylphenyl)carbonyl]amino}benzoic acid |

519 | 2924 29 98 | 150812-23-0 | ethyl {4-[(4-fluorobenzyl)amino]-2-nitrophenyl}carbamate |

237 | 2924 29 98 | 22316-45-6 | ethyl 3-[(5-chloro-2-nitrophenyl)(phenyl)amino]-3-oxopropanoate |

3 | 2924 29 98 | 316173-29-2 | methyl (1S,2S,3S,4R)-3-[(1S)-1-amino-2-ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-hydroxycyclopentanecarboxylate |

378 | 2924 29 98 | 1142-20-7 | N-benzyloxycarbonyl-L-alanine |

102 | 2924 29 98 | 84996-93-0 | N-cyclohexyl-5-hydroxypentanamide |

270 | 2924 29 98 | 579494-66-9 | propyl {4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxyphenyl}acetate |

533 | 2925 19 95 | 265136-65-0 | ethyl 3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]but-2-enoate |

33 | 2926 90 95 | 855425-38-6 | 1-(2-ethylbutyl)cyclohexanecarbonitrile |

537 | 2926 90 95 | 846023-24-3 | 2-cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide |

417 | 2926 90 95 | 591769-05-0 | 3-cyclopentylprop-2-enenitrile |

50 | 2926 90 95 | 20099-89-2 | 4-(bromoacetyl)benzonitrile |

54 | 2926 90 95 | 474554-45-5 | 4,5-diethoxy-3-fluorobenzene-1,2-dicarbonitrile |

587 | 2926 90 95 | 79370-78-8 | 5-hydroxybenzene-1,3-dicarbonitrile |

118 | 2926 90 95 | 139481-28-0 | methyl 2-{[(2'-cyanobiphenyl-4-yl)methyl]amino}-3-nitrobenzoate |

182 | 2928 00 90 | 860035-10-5 | 1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate |

403 | 2928 00 90 | 910656-45-0 | 2-hydroxy-2-(trifluoromethyl)butanehydrazide |

104 | 2928 00 90 | 95759-10-7 | 4-chloro-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid |

383 | 2928 00 90 | 473927-63-8 | ethyl (2Z)-chloro[2-(4-methoxyphenyl)hydrazinylidene]ethanoate |

144 | 2928 00 90 | 158671-29-5 | N,2-dihydroxy-4-methylbenzamide |

106 | 2928 00 90 | 84080-68-2 | tert-butyl (2Z)-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoate |

105 | 2928 00 90 | 268544-50-9 | tert-butyl-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoate |

101 | 2930 90 85 | 13459-62-6 | {2-[(4-chlorophenyl)sulfanyl]phenyl}acetic acid |

20 | 2930 90 85 | 211513-21-2 | 1-(2-ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxamide |

181 | 2930 90 85 | 860035-07-0 | 1-{[(methylsulfanyl)carbonyl]oxy}ethyl 2-methylpropanoate |

396 | 2930 90 85 | 893407-18-6 | 2,2,2-trifluoro-1-[4'-(methylsulfonyl)biphenyl-4-yl]ethanone |

86 | 2930 90 85 | 60759-00-4 | 3,4-diethoxybenzenecarbothioamide |

180 | 2930 90 85 | 21048-05-5 | N-methylbenzenecarbothiohydrazide |

47 | 2931 00 95 | 13682-94-5 | (2-bromoethenyl)(trimethyl)silane |

46 | 2931 00 95 | 914922-89-7 | (2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-methoxy-N,2-dimethyl-7-oxoheptanamide |

44 | 2931 00 95 | 914922-88-6 | (2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N,2-dimethyloct-7-enamide |

45 | 2931 00 95 | 871355-80-5 | (4R)-2-bromo-7-{[tert-butyl(diphenyl)silyl]oxy}hept-1-en-4-yl 4-methylbenzenesulfonate |

192 | 2931 00 95 | 89694-48-4 | (5-chloro-2-methoxyphenyl)boronic acid |

359 | 2931 00 95 | 701278-08-2 | [(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-methoxypropan-2-yl)oxy]methyl}cyclopent-2-en-1-yl]methanol |

360 | 2931 00 95 | 701278-09-3 | {(4S,5R)-5-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]cyclopent-1-en-1-yl}methanol |

318 | 2931 00 95 | 796967-18-5 | 1-(2-fluoro-5-methylphenyl)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea |

52 | 2931 00 95 | 172732-52-4 | 2-(1,3,2-dioxaborinan-2-yl)benzonitrile |

48 | 2931 00 95 | 185411-12-5 | methyl 3-(trimethylsilyl)pent-4-enoate |

43 | 2932 19 00 | 253128-10-8 | (1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-[(2S,5S)-5-(3-hydroxypropyl)-3-methylidenetetrahydrofuran-2-yl]ethyl}-3-methyl-9-O-methyl-4-methylidene-8-[(phenylsulfonyl)methyl]-D-arabino-D-altro-tridecitol |

571 | 2932 19 00 | 441045-17-6 | (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-bis(methylene)-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one methanesulfonate |

35 | 2932 29 85 | 916069-80-2 | (4S)-4-(fluoromethyl)dihydrofuran-2(3H)-one |

554 | 2932 29 85 | 63106-93-4 | 1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |

140 | 2932 29 85 | 7734-80-7 | 2-oxo-2H-chromene-6-carboxylic acid |

399 | 2932 29 85 | 0-00-0 | 4-(4-fluorophenyl)-7-(isothiocyanatomethyl)-2H-chromen-2-one |

142 | 2932 29 85 | 947408-91-5 | 6-[(2,4-dihydroxyphenyl)carbonyl]-2H-chromen-2-one |

141 | 2932 29 85 | 947408-90-4 | 6-[(2,4-dimethoxyphenyl)carbonyl]-2H-chromen-2-one |

165 | 2932 99 00 | 452342-08-4 | (1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol |

206 | 2932 99 00 | 99541-23-8 | (1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-7,8-bis(benzyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-3-yl acetate |

389 | 2932 99 00 | 461432-25-7 | (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol |

116 | 2932 99 00 | 196597-79-2 | (2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylideneethanenitrile |

550 | 2932 99 00 | 3308-94-9 | 2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane |

568 | 2932 99 00 | 274693-53-7 | [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]carbamate |

61 | 2932 99 00 | 185954-98-7 | [6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-(3-metoxydecyl)-6-methyl-2-[(1-oxo-11-octadecenyl)amino]-4-O-phosphono-β-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-α-D-glucopyranose 1-(dihydrogen phosphate) tetrasodium salt |

203 | 2932 99 00 | 136172-58-2 | 1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose |

115 | 2932 99 00 | 196597-80-5 | 2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethanamine hydrochloride |

354 | 2932 99 00 | 666860-59-9 | 2-amino-2-oxoethyl{3-[trans-5-(6-methoxynaphthalen-1-yl)-1,3-dioxan-2-yl]propyl}carbamate |

576 | 2932 99 00 | 117661-72-0 | 5-(chloromethyl)-6-methyl-1,3-benzodioxole |

405 | 2932 99 00 | 959624-24-9 | 6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-chromen-2-ol |

388 | 2932 99 00 | 960404-59-5 | but-2-yne-1,4-diol -- methyl 1-C-[4-chloro-3-(4-ethoxybenzyl)phenyl]-α-D-glucopyranoside (1:1) |

13 | 2932 99 00 | 15826-37-6 | disodium 5,5'-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate) |

28 | 2932 99 00 | 204254-84-2 | ethyl (3aR,7R,7aR)-2,2-dimethyl-7-[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-benzodioxole-5-carboxylate |

205 | 2932 99 00 | 99541-26-1 | methyl (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-2H-pyran-2-carboxylate |

204 | 2932 99 00 | 114869-97-5 | methyl 6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-methyl-α-L-idopyranuronosyl)-3-O-benzyl-2-{[(benzyloxy)carbonyl]amino}-2-deoxy-α-D-glucopyranoside |

478 | 2933 19 90 | 1035677-60-1 | (4S)-3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide 2,3-dihydroxybutanedioate |

194 | 2933 19 90 | 18048-64-1 | 2-(3,4-dimethylphenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one |

477 | 2933 19 90 | 1035675-24-1 | 3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide |

310 | 2933 19 90 | 1028026-83-6 | 5-methyl-1-(propan-2-yl)-4-[4-(propan-2-yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-one |

585 | 2933 19 90 | 473921-12-9 | 5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile |

89 | 2933 29 90 | 65902-59-2 | 2-bromo-4-nitro-1H-imidazole |

90 | 2933 29 90 | 57531-37-0 | 2-chloro-4-nitro-1H-imidazole |

24 | 2933 29 90 | 1000164-35-1 | 3-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidyl-2-methylalanyl-L-α-glutamylglycine |

488 | 2933 29 90 | 152074-97-0 | L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine |

489 | 2933 29 90 | 781666-30-6 | L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine tetraacetate |

176 | 2933 29 90 | 451470-33-0 | methyl 3'-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)biphenyl-3-carboxylate |

348 | 2933 39 99 | 925978-49-0 | (+)-5-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1-azabicyclo[3.2.1]octane |

325 | 2933 39 99 | 876170-44-4 | (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate |

1 | 2933 39 99 | 741705-70-4 | (2R)-phenyl[(2R)-piperidin-2-yl]ethanoic acid hydrochloride |

162 | 2933 39 99 | 414910-13-7 | (2S)-hydroxy(phenyl)ethanoic acid -- (2R)-2-(4-fluoro-2-methylphenyl)piperidin-4-one (1:1) |

314 | 2933 39 99 | 0-00-0 | (3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole 4-methylbenzenesulfonate |

315 | 2933 39 99 | 370882-57-8 | (3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-b]pyrrole dihydrochloride |

121 | 2933 39 99 | 334618-23-4 | (3R)-piperidin-3-amine dihydrochloride |

579 | 2933 39 99 | 1062580-52-2 | (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |

578 | 2933 39 99 | 27262-47-1 | (S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide |

183 | 2933 39 99 | 105812-81-5 | [(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl]methanol |

324 | 2933 39 99 | 876068-51-8 | [(3S,4S)-4-amino-1-(5,6-dichloropyridin-3-yl)pyrrolidin-3-yl]methanol |

408 | 2933 39 99 | 871022-14-9 | 1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-benzimidazol-1-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)cyclobutanecarboxylic acid |

549 | 2933 39 99 | 5421-92-1 | 1-(pyridin-4-yl)pyridinium chloride hydrochloride |

541 | 2933 39 99 | 272776-12-2 | 1,1'-binaphthalene-2,2'-diol -- 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole (1:1) |

409 | 2933 39 99 | 871022-19-4 | 1-[(4-{[(tert-butoxycarbonyl)amino]methyl}piperidin-1-yl)methyl]cyclobutanecarboxylic acid |

414 | 2933 39 99 | 3613-73-8 | 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |

535 | 2933 39 99 | 179687-79-7 | 2-[(2-chloro-4-nitrophenoxy)methyl]pyridine |

201 | 2933 39 99 | 122321-04-4 | 2-[methyl(pyridin-2-yl)amino]ethanol |

311 | 2933 39 99 | 945405-37-8 | 2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridine 2,3-dihydroxybutanedioate |

155 | 2933 39 99 | 936637-40-0 | 3,3'-piperidine-1,4-diyldipropan-1-ol 4-methylbenzenesulfonate |

40 | 2933 39 99 | 88150-62-3 | 3-ethyl-5-methyl-4-(2-chlorophenyl)-2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |

404 | 2933 39 99 | 84100-54-9 | 4-(ethylamino)piperidine-4-carboxamide |

157 | 2933 39 99 | 873546-30-6 | 4,4'-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]bis(N'-hydroxybenzenecarboximidamide) |

158 | 2933 39 99 | 873546-74-8 | 4,4'-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]bis[N'-(acetyloxy)benzenecarboximidamide] |

159 | 2933 39 99 | 873546-38-4 | 4,4'-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]dibenzenecarboximidamide trihydrochloride pentahydrate |

156 | 2933 39 99 | 873546-80-6 | 4,4'-[piperidine-1,4-diylbis(propane-3,1-diyloxy)]dibenzonitrile |

316 | 2933 39 99 | 78750-61-5 | 4-[(3-nitropyridin-2-yl)amino]phenol |

87 | 2933 39 99 | 866109-93-5 | 4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenol 4-methylbenzenesulfonate |

472 | 2933 39 99 | 927889-51-8 | 4-bromo-2,6-diethylpyridine 4-methylbenzenesulfonate |

272 | 2933 39 99 | 691882-47-0 | 4-hydroxybenzoic acid -- (2S,4E)-N-methyl-5-[5-(propan-2-yloxy)pyridin-3-yl]pent-4-en-2-amine (1:1) |

323 | 2933 39 99 | 876068-46-1 | 5,6-dichloro-N-(2,2-dimethoxyethyl)pyridin-3-amine |

220 | 2933 39 99 | 1072-98-6 | 5-chloropyridin-2-amine |

85 | 2933 39 99 | 298692-34-9 | 6-(chloroacetyl)pyridine-2-carboxylic acid |

349 | 2933 39 99 | 550349-58-1 | 7-chloro-3-(6-methoxypyridin-3-yl)-N,N,5-trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-b]indole-1-carboxamide |

160 | 2933 39 99 | 414909-98-1 | benzyl 2-(4-fluoro-2-methylphenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate |

164 | 2933 39 99 | 56880-11-6 | ethyl [(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)acetate |

273 | 2933 39 99 | 548797-97-3 | N-(2-{[(2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl]oxy}-4-hydroxyphenyl)acetamide |

352 | 2933 39 99 | 0-00-0 | N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]-2,6-dichloro-3-(trifluoromethyl)benzamide hydrochloride |

289 | 2933 39 99 | 329003-65-8 | sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate hemipentahydrate |

58 | 2933 49 10 | 417716-92-8 | 4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide methanesulfonate |

584 | 2933 49 90 | 503291-53-0 | 2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chloro-2-(1H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolinecarboxylate 4-methylbenzenesulfonate |

539 | 2933 49 90 | 103733-32-0 | benzyl (3S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride |

581 | 2933 49 90 | 503293-98-9 | (3S,4aS,6S,8aR)-6-hydroxy-2-(methoxycarbonyl)decahydroisoquinoline-3-carboxylic acid |

583 | 2933 49 90 | 503290-66-2 | (3S,4aS,6S,8aR)-6-[3-chloro-2-(2H-tetrazol-5-yl)phenoxy]decahydro-3-isoquinolinecarboxylic acid hydrochloride |

580 | 2933 49 90 | 134388-95-7 | (3S,4aS,8aR)-2-(methoxycarbonyl)-6-oxodecahydroisoquinoline-3-carboxylic acid -- (1R)-1-phenylethanamine (1:1) |

328 | 2933 49 90 | 868210-14-4 | 4-(4-{[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-2-methyl-3,4-dihydroquinolin-1(2H)-yl]carbonyl}phenoxy)-2,2-dimethylbutanoic acid |

545 | 2933 49 90 | 00-00-0 | methyl 2-[(3R)-3-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-({[1-(hydroxymethyl)cyclopropyl]methyl}sulfanyl)propyl]benzoate hydrochloride |

534 | 2933 49 90 | 848133-76-6 | N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide |

479 | 2933 59 95 | 869490-23-3 | (3,3-difluoropyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl}methanone |

421 | 2933 59 95 | 941685-40-1 | (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |

416 | 2933 59 95 | 941678-49-5 | (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |

420 | 2933 59 95 | 941685-41-2 | (3S)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |

394 | 2933 59 95 | 957187-34-7 | [(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetic acid |

190 | 2933 59 95 | 356058-42-9 | {2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}acetic acid |

395 | 2933 59 95 | 0-00-0 | 2,3-dihydroxy-2,3-bis(phenylcarbonyl)butanedioic acid -- ethyl [(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]dec-9-yl]acetate (1:1) |

407 | 2933 59 95 | 90213-66-4 | 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine |

197 | 2933 59 95 | 3934-20-1 | 2,4-dichloropyrimidine |

189 | 2933 59 95 | 451487-18-6 | 2-[(4-fluorobenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one |

120 | 2933 59 95 | 865758-96-9 | 2-[(6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]benzonitrile |

340 | 2933 59 95 | 934815-71-1 | 2-[3-(6-{[2-(2,4-dichlorophenyl)ethyl]amino}-2-methoxypyrimidin-4-yl)phenyl]-2-methylpropanoic acid phosphate |

278 | 2933 59 95 | 722543-31-9 | 2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-yl}oxy)propyl]amino}ethyl dihydrogen phosphate |

361 | 2933 59 95 | 1032066-96-8 | 2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl}-1,9-dihydro-6H-purin-6-one -- methanesulfonate (2:1) |

406 | 2933 59 95 | 540737-29-9 | 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate |

400 | 2933 59 95 | 1137917-12-4 | 3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-hydroxypropan-2-yl]oxy}benzoic acid -- 1,4-diazabicyclo[2.2.2]octane (2:1) |

422 | 2933 59 95 | 941685-39-8 | 3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |

419 | 2933 59 95 | 941685-27-4 | 4-(1H-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine |

365 | 2933 59 95 | 1780-26-3 | 4,6-dichloro-2-methylpyrimidine |

567 | 2933 59 95 | 145783-14-8 | 4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine |

423 | 2933 59 95 | 3680-69-1 | 4-chloro-7H-pyrrolo[2,3-d]pyrimidine |

215 | 2933 59 95 | 61379-64-4 | 4-cyclopentylpiperazin-1-amine |

219 | 2933 59 95 | 55112-42-0 | 4-methylpiperazine-1-carbonyl chloride hydrochloride |

338 | 2933 59 95 | 0-00-0 | 5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-methylpiperazin-1-yl)[1,2,4]triazolo[1,5-a]quinoline-4-carbonitrile -- (2E)-but-2-enedioate (2:1) hydrate |

471 | 2933 59 95 | 55293-96-4 | 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-carbaldehyde |

288 | 2933 59 95 | 179688-01-8 | 7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one |

198 | 2933 59 95 | 444731-74-2 | N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine |

355 | 2933 59 95 | 0-00-0 | N-(5-fluoro-3-methyl-1H-indol-1-yl)-4-methyl-2-(pyridin-2-yl)pyrimidine-5-carboxamide |

484 | 2933 79 00 | 586414-48-4 | (-)-3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide |

486 | 2933 79 00 | 425663-71-4 | (1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride |

34 | 2933 79 00 | 813452-14-1 | (4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl]-4-(fluoromethyl)pyrrolidin-2-one dihydrochloride |

77 | 2933 79 00 | 5162-90-3 | 3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine |

384 | 2933 79 00 | 536760-29-9 | 3-chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one |

78 | 2933 79 00 | 4876-10-2 | 4-(bromomethyl)quinolin-2(1H)-one |

69 | 2933 79 00 | 5057-12-5 | 4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione |

72 | 2933 79 00 | 54197-66-9 | 6-hydroxy-3,4-dihydroquinolin-2(1H)-one |

75 | 2933 79 00 | 22246-18-0 | 7-hydroxy-3,4-dihydroquinolin-2(1H)-one |

380 | 2933 79 00 | 536759-91-8 | ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |

382 | 2933 79 00 | 503614-91-3 | ethyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |

485 | 2933 79 00 | 586379-61-5 | methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate |

368 | 2933 99 80 | 709031-45-8 | (1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate |

376 | 2933 99 80 | 649735-46-6 | (2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol |

276 | 2933 99 80 | 51077-14-6 | (2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylic acid |

277 | 2933 99 80 | 631916-97-7 | (2S)-N-{4-[(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyethanoyl}azetidine-2-carboxamide --benzenesulphonic acid (1:1) |

564 | 2933 99 80 | 80875-98-5 | (2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid |

313 | 2933 99 80 | 948846-40-0 | (2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butanedioic acid -- ethyl (3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate (1:1) |

302 | 2933 99 80 | 1000164-36-2 | (5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butan-2-yl]-14,38-bis{4-[(tert-butoxycarbonyl)amino]butyl}-29-{[1-(tert-butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-(propan-2-yl)-2-oxa-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaazadotetracontan-42-oic acid |

529 | 2933 99 80 | 22162-51-2 | 1-(2-nitrobenzyl)-1H-pyrrole-2-carbaldehyde |

410 | 2933 99 80 | 35681-40-4 | 1-(propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one |

522 | 2933 99 80 | 166170-15-6 | 1-(tert-butoxycarbonyl)-2-methyl-D-proline |

322 | 2933 99 80 | 796967-16-3 | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea |

321 | 2933 99 80 | 0-00-0 | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea hydrochloride |

196 | 2933 99 80 | 444731-72-0 | 2,3-dimethyl-2H-indazol-6-amine |

415 | 2933 99 80 | 19686-05-6 | 2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |

524 | 2933 99 80 | 912444-00-9 | 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide |

523 | 2933 99 80 | 912445-36-4 | 2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide dihydrochloride |

481 | 2933 99 80 | 163457-23-6 | 3,3-difluoropyrrolidine hydrochloride |

65 | 2933 99 80 | 239463-85-5 | 3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-indol-1-yl}propyl benzoate (2R,3R)-2,3-dihydroxybutanedioate |

150 | 2933 99 80 | 55321-99-8 | 3-oxo-3,4-dihydropyrazine-2-carboxamide |

375 | 2933 99 80 | 952490-01-6 | 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate |

274 | 2933 99 80 | 942436-93-3 | 4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide |

275 | 2933 99 80 | 942437-37-8 | 4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide |

285 | 2933 99 80 | 288385-88-6 | 4-fluoro-2-methyl-1H-indol-5-ol |

582 | 2933 99 80 | 503293-47-8 | 5-(2-chloro-6-fluorophenyl)-2H-tetrazole |

71 | 2933 99 80 | 73963-42-5 | 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole |

271 | 2933 99 80 | 606143-52-6 | 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide |

347 | 2933 99 80 | 0-00-0 | 5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-indole-2-carboxamide |

373 | 2933 99 80 | 872206-47-8 | 5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate |

151 | 2933 99 80 | 259793-88-9 | 6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide |

562 | 2933 99 80 | 1137606-74-6 | 6-fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile -- N-cyclohexylcyclohexanamine (1:1) |

482 | 2933 99 80 | 261953-36-0 | 6-iodo-1H-indazole |

73 | 2933 99 80 | 80076-47-7 | 8,9-difluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid |

188 | 2933 99 80 | 52602-39-8 | 9H-carbazol-4-ol |

235 | 2933 99 80 | 145641-35-6 | benzyl (2S,3aR,7aS)-octahydro-1H-indole-2-carboxylate hydrochloride |

540 | 2933 99 80 | 87269-87-2 | benzyl (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-2-carboxylate hydrochloride |

21 | 2933 99 80 | 1012065-72-3 | ethyl 2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline-3-carboxylate |

563 | 2933 99 80 | 131707-24-9 | ethyl 6-bromo-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate |

124 | 2933 99 80 | 105152-95-2 | ethyl 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate |

117 | 2933 99 80 | 139481-44-0 | methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate |

393 | 2933 99 80 | 0-00-0 | methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-b]pyridine-3-carboxylate |

555 | 2933 99 80 | 21688-11-9 | N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide |

370 | 2933 99 80 | 361440-67-7 | tert-butyl (1S,3S,5S)-3-carbamoyl-2-azabicyclo[3.1.0]hexane-2-carboxylate |

371 | 2933 99 80 | 709031-38-9 | tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrole-1-carboxylate |

366 | 2933 99 80 | 709031-43-6 | tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamate |

588 | 2933 49 90 | 936359-25-0 | methyl 2-((R)-3-(3-((E)-2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(((1-(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl)benzoate |

341 | 2934 10 00 | 110130-88-6 | (2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-yl)ethanoic acid |

547 | 2934 10 00 | 68672-66-2 | (2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-yl]ethanoic acid |

202 | 2934 10 00 | 291536-35-1 | (5Z)-5-(4-fluorobenzylidene)-1,3-thiazolidine-2,4-dione |

362 | 2934 10 00 | 302964-24-5 | 2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide |

339 | 2934 10 00 | 866920-24-3 | 3-[2-chloro-4-({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-one |

353 | 2934 10 00 | 752253-39-7 | 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amine |

57 | 2934 10 00 | 914361-45-8 | L-lysine -- {[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1- yl)butan-2-yl]oxy}methyl dihydrogen phosphate -- ethanol (1:1:1) |

363 | 2934 10 00 | 302964-08-5 | N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide |

107 | 2934 10 00 | 127660-04-2 | sodium (2Z)-(2-amino-1,3-thiazol-4-yl)(hydroxyimino)ethanoate |

135 | 2934 99 90 | 17381-54-3 | (1-benzothiophen-5-yl)acetic acid |

60 | 2934 99 90 | 630100-90-2 | (1R)-1,2-anhydro-4-C-{(1E,3E)-4-[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-2-yl]-D-erythropentitol |

283 | 2934 99 90 | 220099-91-2 | (2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridine] |

282 | 2934 99 90 | 220100-81-2 | (2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridine] (S,S)-2,3-dihydroxybutanedioate |

29 | 2934 99 90 | 161599-46-8 | (2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate |

30 | 2934 99 90 | 690270-65-6 | (2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-azido-2-{[(2-methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) hydrochloride |

392 | 2934 99 90 | 265121-04-8 | (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(2-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid -- 1-deoxy-1-(methylamino)-D-glucitol (1:2) |

126 | 2934 99 90 | 163680-80-6 | (3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |

544 | 2934 99 90 | 132335-46-7 | (3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |

345 | 2934 99 90 | 133413-70-4 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone |

169 | 2934 99 90 | 503068-36-8 | (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one |

166 | 2934 99 90 | 452339-73-0 | (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one |

470 | 2934 99 90 | 877130-28-4 | (6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-2H-pyran-2-one |

543 | 2934 99 90 | 132335-44-5 | (S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol |

31 | 2934 99 90 | 812647-80-6 | {(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-yl}methyl 3-chlorobenzoate |

551 | 2934 99 90 | 00-00-0 | 1-(1-{4-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one |

418 | 2934 99 90 | 1029716-44-6 | 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |

358 | 2934 99 90 | 165172-60-1 | 1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione -- 1-methylpyrrolidin-2-one (1:1) |

139 | 2934 99 90 | 519187-97-4 | 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-azetidinol -- (2Z)-2-butenedioate (1:1) |

49 | 2934 99 90 | 127000-90-2 | 1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole |

332 | 2934 99 90 | 710281-33-7 | 2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy}methyl)-6-methylbenzoic acid |

136 | 2934 99 90 | 96803-30-4 | 2-(1-benzothiophen-5-yl)ethanol |

59 | 2934 99 90 | 913695-00-8 | 2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-dimethylpyridin-2-yl}methyl)sulfinyl]-1Hbenzimidazole, salann sóidiam (1:1) |

286 | 2934 99 90 | 376608-74-1 | 2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloro-2-(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol |

55 | 2934 99 90 | 474554-48-8 | 2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-yl)phenyl]ethanone |

148 | 2934 99 90 | 530141-72-1 | 3-(5-{[4-(cyclopentyloxy)-2-hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-benzoxazol-6-yl)methoxy]phenyl)propanoic acid |

138 | 2934 99 90 | 519188-55-7 | 3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-hydroxyazetidin-1-yl)propan-1-one |

137 | 2934 99 90 | 519188-42-2 | 3-[2-(1-benzothiophen-5-yl)ethoxy]propionic acid |

566 | 2934 99 90 | 753015-42-8 | 3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-(tetrahydro-2H-pyran-4-yloxy)pyridine |

557 | 2934 99 90 | 26638-53-9 | 3-chloro-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide |

153 | 2934 99 90 | 499785-81-8 | 3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide |

154 | 2934 99 90 | 356782-84-8 | 3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazine-2-carboxamide |

211 | 2934 99 90 | 6504-57-0 | 4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-methylmorpholin-4-ium methyl sulfate |

329 | 2934 99 90 | 871484-32-1 | 4-[4-({3-[(4-deoxy-4-fluoro-b-D-glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-yl}methyl)phenyl]-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]butanamide |

575 | 2934 99 90 | 166964-09-6 | 4-chloro-3-methyl-1,2-oxazol-5-amine |

93 | 2934 99 90 | 655233-39-3 | 4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride |

542 | 2920 90 85 | 89729-09-9 | 5,7-dioxa-6-thiaspiro[2.5]octane-6-oxide |

172 | 2934 99 90 | 388082-75-5 | 5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde 4-methylbenzenesulfonate (1:1) |

134 | 2934 99 90 | 4923-87-9 | 5-bromo-1-benzothiophene |

146 | 2934 99 90 | 947408-95-9 | 6-(bromomethyl)-2-triphenylmethyl-1,2-benzisoxazol-3(2H)-one |

145 | 2934 99 90 | 947408-94-8 | 6-methyl-2-trityl-1,2-benzoxazol-3(2H)-one |

110 | 2934 99 90 | 67978-05-6 | diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoate |

357 | 2934 99 90 | 1001859-46-6 | DNA (veicteoir phlasmaideach shintéiseach pCOR a réalaíonn leáphróitéin ina bhfuil peiptíd de chomhartha beta d'inteirféarón daonna ag a bhfuil tosca fáis d'fhibreablast daonna ar a bhfuil an t-aimínaigéad 21- 154) |

326 | 2934 99 90 | 665058-78-6 | DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-Gsp- T-sp-C-G-sp-T-sp-T) |

401 | 2934 99 90 | 923591-06-4 | methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-carboxylate |

577 | 2934 99 90 | 59337-92-7 | Methyl 3-(chlorosulfonyl)thiophene-2-carboxylate |

147 | 2934 99 90 | 947409-01-0 | methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on- 6-yl)methoxy]phenyl]propionate |

212 | 2934 99 90 | 85006-31-1 | Methyl 3-amino-4-methylthiophene-2-carboxylate |

280 | 2934 99 90 | 893428-72-3 | N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine -- (2E)-2-butenedioate (1:2) |

18 | 2934 99 90 | 390800-88-1 | N,N',N''-(boroxin-2,4,6-triyltris{[(1S)-3-methylbutane-1,1-diyl]imino[(2S)-1-oxo-3-phenylpropane-1,2-diyl]})tripyrazine-2-carboxamide |

99 | 2934 99 90 | 112913-94-7 | N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}acetamide |

412 | 2934 99 90 | 120788-03-6 | S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] ethanethioate |

402 | 2935 00 90 | 1198178-65-2 | (1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropanaminium 4-methylbenzenesulfonate |

556 | 2935 00 90 | 39570-96-2 | (2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}- 3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-methylphenyl)sulfonyl]amino}propanamide |

79 | 2935 00 90 | 24310-36-9 | 1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one |

346 | 2935 00 90 | 0-00-0 | 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide di[(2E)-but-2-enedioate] hydrate |

281 | 2935 00 90 | 941690-55-7 | 3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide |

199 | 2935 00 90 | 6973-09-7 | 5-amino-2-methylbenzenesulfonamide |

82 | 2935 00 90 | 193686-76-9 | 7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one |

130 | 2935 00 90 | 123664-84-6 | N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide |

133 | 2935 00 90 | 149457-03-4 | N-[4-(N-formylglycyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide |

132 | 2935 00 90 | 149456-98-4 | N-[4-(N-formylglycyl)-5-methoxy-2-phenoxyphenyl]methanesulfonamide |

319 | 2935 00 90 | 141450-48-8 | N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide hydrochloride |

391 | 2935 00 90 | 289042-10-0 | N-{5-[(diphenylphosphoryl)methyl]-4-(4-fluorophenyl)-6-(propan-2-yl)pyrimidin-2-yl}-N-methylmethanesulfonamide |

187 | 2939 99 00 | 7689-03-4 | (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |

239 | 2939 99 00 | 477-29-2 | Colchicoside |

173 | 2940 00 00 | 604-69-3 | 1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose |

333 | 2940 00 00 | 647834-15-9 | 2-(4-methoxybenzyl)thiophen-3-yl β-D-glucopyranoside |

127 | 2941 90 00 | 76610-92-9 | (6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-threonyl}amino)-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |

570 | 3907 20 99 | 913976-27-9 | poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, diester le 21N6, 21’N6-[[(N2, N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2, 1-ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide] cyclic (6→15), (6’→15’) bis(disulfide) |

IARSCRÍBHINN IV

Liosta na dtáirgí idirmheánacha cógaisíochta, i.e. comhdhúile a úsáidtear chun táirgí críochnaithe cógaisíochta a mhonarú, agus atá le baint ó liosta na dtáirgí a ndéileáiltear leo ar bhonn saor ó dhleacht agus atá ar áireamh in Iarscríbhinn 6 d'Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87 ós rud é go bhfuil siad curtha ar liosta na dtáirgí a ndéileáiltear leo ar bhonn saor ó dhleacht agus atá ar áireamh in Iarscríbhinn 3 d'Iarscríbhinn I a ghabhann le Rialachán (CEE) Uimh. 2658/87

Cód AC | Uimh. CAS RN | Ainm |

2915 39 00 2937 29 00 | 7753-60-8 | 17-alpha-hydroxy-3,20-dioxopregna-4,9(11)-diene-21-yl acetate féach anecortave (ANI) |

2920 90 85 | 163133-43-5 | 4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl)propanoate féach naproxcinod (ANI) |

2924 29 98 | 194085-75-1 | 2-(2-chlorophenyl)-2-hydroxyethyl carbamate féach carisbamate (ANI) |

2933 39 99 | 103129-82-4 | 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate féach levamlodipine (ANI) |

2933 39 99 | 319460-85-0 | N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol-6-yl]sulfanyl}benzamide féach axitinib (ANI) |

2934 10 00 | 302962-49-8 | N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)thiazole-5-carboxamide féach dasatinib (ANI) |

2934 99 90 | 143491-57-0 | (2R,5S)-4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one féach emtricitabine (ANI) |

2934 99 90 | 98819-76-2 | (2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine féach esreboxetine (ANI) |

2934 99 90 | 475479-34-6 | (2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid féach aleglitazar (ANI) |

2934 99 90 | 377727-87-2 | 2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-5-amine féach preladenant (ANI) |

2934 99 90 | 189003-92-7 | 2-{7-fluoro-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-ylpiperazin-1-yl)ethyl]quinolin-1(2H)-yl}acetamide féach trelanserin (ANI) |

2934 99 90 | 134379-77-4 | 4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-one féach dexelvucitabine (ANI) |

2934 99 90 | 518048-05-0 | potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-(5-methyl-1,3,4-oxadiazole-2-carboxamido)ethyl]-6-oxo-1,6-dihydropyrimidine-5-olate féach raltegravir (ANI) |

2935 00 90 | 170569-88-7 | 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzene-1-sulfonamide féach mavacoxib (ANI) |

2935 00 90 | 186497-07-4 | N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide féach zibotentan (ANI) |

[1] IO L 256, 7.9.1987, lch. 1.